| |
John
Goudreau leads one of 51 clinical centers investigating whether the
nutritional supplement creatine can slow the progression of Parkinson’s
disease. Pilot studies suggest creatine, which supports energy production in
brain cells affected by the disease, may be effective. The large, controlled
clinical trial aims to determine if the drug prevents progression of the
disease to later stages where management of symptoms becomes more difficult.
When
Arshad Majid
gave mice the dietary supplement carnosine before a stroke, he found that
severity of the stroke was consistently reduced by as much as half. The
substance, which occurs naturally in brain and muscle tissue, even helps
after onset of stroke symptoms, reducing severity up to 40 percent. If the
effect transfers to people, the nontoxic substance could reduce incidence of
disability associated with stroke.
Downy mildew can kill a melon, cucumber, or yellow
squash crop in seven to ten days. The fungus reproduces via microscopic
spores that thrive in humid, wet weather and spread quickly.
Mary
Hausbeck conducted trials to help growers determine which fungicide
would work best to control the devastating disease. Frequent spraying will
control crop damage but cause production costs to increase substantially.
A new magnetic resonance imaging (MRI) unit, the first
in Malawi, means the country’s single radiologist can send images to MSU for
evaluation. And
Terrie Taylor
can look at brain activity of living malaria patients rather than depending
on autopsy results to learn how the disease affects the brain. So far
autopsy studies of children show that some of them died from unrelated
infections or diseases. Better diagnoses will mean better treatment.
Like
people, more dogs and cats than ever are being diagnosed with cancer—as many
as half after age 10.
Barbara Kitchell
found that dogs have a particularly high incidence of osteosarcoma and it
closely resembles the bone cancer that afflicts children. She directs a new
clinic where such companion animals have access to the newest diagnostic
procedures and medications in clinical trials that can translate to care for
human patients. |
John
Goudreau, associate professor of neurology and ophthalmology,
517-353-8122
Mary Hausbeck,
professor of plant pathology, 517-355-4534
Barbara Kitchell,
professor of small animal clinical sciences,
517-353-5420
Arshad Majid,
associate professor of neurology and ophthalmology,
517-353-8122x140
Terrie Taylor,
University Distinguished Professor of internal medicine,
517-353-8975 |